Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Next Generation Technology for Gastric Disorders
Alesi Surgical develops and commercialises products that improve the safety
GraphEnergyTech focuses on the power of graphene for solar cells.
Hysata develops hydrogen electrolyzers aimed at advancing the global transition from fossil fuels to green hydrogen.
A UK-based developer of drugs to treat respiratory diseases
C-Capture develops a solvent-based technology that offers a safe, low-cost way to remove carbon dioxide from emissions.
Molendotech manufactures a device to test water for faecal contamination.
Additive Assurance offers quality assurance for metal additive manufacturing.
WaveOptics designs Augmented Reality (AR) wearables with enhanced features.
CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care.
Uniphy is an electronic company that enables intuitive free-form Touch Interfaces that are beautiful, robust and economic.
Talivest is a people analytics SaaS company, specialising in employee engagement through innovative technology solutions.
SAM Labs is an edtech company that empowers teachers with the most engaging STEAM solution.
8power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications.
Ultraleap is working to create the most remarkable connection between people and technology.
RAGE Biotech is a biotechnology industry.
Amprologix Ltd is a world-leading biotechnology and synthetic biology company Ingenza.
Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Econic Technologies develops new catalysts and processes for the manufacture of polymers from CO2.
MITEK Medical Materials focuses on the research and development and supply of medical-grade bioactive/bioenergy medical materials.
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
OXCCU develops technology to convert carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics.
AMSL Aero is a developer of electric vertical take-off and landing aircraft.
Azaneo develops lightning-fast electric weeding technology. Using only electrons - herbicide free.
IP Group has invested in 125 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IP Group's top investment sectors include Biotechnology, Health Care, Manufacturing, Therapeutics, Chemical. The firm invests across 57 different industry categories.
Among tracked funding rounds, Hysata received $111.0M in a Series B round. IP Group's total known invested capital is $1.0B.
IP Group's average investment size is $11.3M across its portfolio of 125 companies.
Recent IP Group portfolio additions include Alimetry, Alesi Surgical, GraphEnergyTech, Hysata, Enterprise Therapeutics. These companies were founded in 2020 or later.